Inflammation and Body Pain: Why the Internal Fire Keeps You Hurting

Chronic body pain is one of the most common and debilitating experiences people present with — and one of the most frequently treated without addressing the root cause. Pain is managed with NSAIDs, muscle relaxants, or physiotherapy, while the inflammatory state that's generating the pain continues unchecked. The relationship between inflammation and body pain is mechanistically precise and clinically well-documented. Understanding it — how inflammatory molecules directly activate pain nerves, how gut dysbiosis feeds the inflammatory cycle, how the brain becomes sensitised to amplify pain when inflammation is sustained — changes both the understanding of chronic pain and the approach to addressing it. This blog traces that relationship from the cellular level to the clinical experience.

Table of Contents

• 1. Inflammation and Body Pain: Why the Internal Fire Keeps You Hurting
• 2. Acute vs Chronic Inflammation — Two Completely Different Stories
• 3. How Inflammation Directly Causes Pain — The Cytokine-Nociceptor Pathway
• 4. NF-kB — The Master Switch of Inflammatory Gene Expression
• 5. Prostaglandins and Pain — What NSAIDs Actually Do
• 6. The Gut as an Inflammation Factory — How Dysbiosis Fuels Body Pain
• 7. Neuroinflammation — When Inflammation Reaches the Brain
• 8. Nutritional and Dietary Factors That Drive or Reduce Chronic Inflammation
• 9. FAQs
• 10. Conclusion

Key Benefits

• Acute vs Chronic Inflammation — Two Completely Different Stories
• Inflammation is not inherently pathological. Acute inflammation — the redness, heat, swelling, and pain that follows injury or infection — is a precisely orchestrated, self-resolving immune response. It clears pathogens, removes damaged tissue, and initiates repair. It is supposed to hurt (pain drives protective behaviour), and it is supposed to resolve within days to weeks.
• Chronic systemic inflammation is a completely different biological state. It is:
• • Low-grade (below the threshold that triggers classic acute inflammatory signs)
• • Persistent (sustained for months to years without self-resolution)• Systemic (circulating throughout the body rather than localised)
• • Self-perpetuating (maintains itself through positive feedback loops)• Clinically silent initially — producing fatigue, brain fog, diffuse aching, and disrupted sleep before more obvious pathology appears
• The C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) elevations characteristic of acute inflammation may be absent in chronic low-grade systemic inflammation — which is one reason it goes undetected in standard blood panels. High-sensitivity CRP (hsCRP) and inflammatory cytokine panels are more sensitive markers.

How Inflammation Directly Causes Pain — The Cytokine-Nociceptor Pathway

The direct mechanism through which inflammation and body pain are connected involves pro-inflammatory cytokines and their effect on peripheral nociceptors — the specialised sensory nerve endings that detect and transmit pain signals.

The primary pro-inflammatory cytokines in chronic pain are:

• TNF-alpha (tumour necrosis factor-alpha): Directly sensitises peripheral nociceptors, reducing their activation threshold. Also promotes central sensitisation and contributes to synovial joint inflammation.

• IL-6 (interleukin-6): Acts both peripherally (sensitising nociceptors) and centrally (crossing the blood-brain barrier to promote neuroinflammation and alter HPA axis function). Elevated in fibromyalgia, chronic lower back pain, and post-viral fatigue.

• IL-1beta (interleukin-1 beta): Produced by activated macrophages; promotes prostaglandin synthesis, hyperalgesia, and sickness behaviour (fatigue, pain hypersensitivity, reduced appetite).

These cytokines act on peripheral nociceptors by:

• Activating TRP (transient receptor potential) ion channels on pain fibres, particularly TRPV1 (the capsaicin receptor, which responds to heat and inflammatory mediators)

• Reducing the activation threshold of voltage-gated sodium channels (Nav1.7, Nav1.8 — the sodium channels responsible for pain signal generation)

• Promoting prostaglandin E2 (PGE2) synthesis — the direct target of NSAIDs, which explains why NSAIDs produce short-term relief while leaving the cytokine source untouched

NF-kB — The Master Switch of Inflammatory Gene Expression Nuclear factor kappa B (NF-kB) is the central transcription factor that controls the expression of the majority of pro-inflammatory genes — including TNF-alpha, IL-6, IL-1beta, COX-2 (the cyclooxygenase enzyme that produces inflammatory prostaglandins), and iNOS (inducible nitric oxide synthase). NF-kB is activated by: • Bacterial LPS from gut dysbiosis • Oxidative stress (reactive oxygen species)• Advanced glycation end products (AGEs) from high-sugar diets • Saturated fatty acids and trans fats • Chronic psychological stress (via cortisol and catecholamines)• Smoking, alcohol, and environmental toxins Once activated, NF-kB produces a broad inflammatory response that feeds back on itself — inflammatory cytokines activate NF-kB further, creating the self-sustaining cycle characteristic of chronic inflammation. Anti-inflammatory dietary and nutritional approaches work largely by blocking upstream NF-kB activation — which is why they address the source rather than only the symptoms of inflammatory pain.

Prostaglandins and Pain — What NSAIDs Actually Do Prostaglandins — particularly PGE2 — are the immediate inflammatory mediators responsible for pain sensitisation, fever, and oedema at sites of inflammation. They are produced from arachidonic acid (an omega-6 fatty acid) via the COX-2 enzyme. NSAIDs (ibuprofen, naproxen, aspirin) inhibit COX-2, reducing PGE2 production and providing temporary pain relief. This is genuinely useful for acute inflammation. The problem with chronic use: NSAIDs don't reduce cytokine production (TNF-alpha, IL-6) or NF-kB activation — the upstream drivers. When NSAIDs are stopped, the pro-inflammatory environment that was generating PGE2 is unchanged, and pain returns. Chronic NSAID use also damages the gut lining, worsening intestinal permeability and gut dysbiosis — increasing systemic inflammation and potentially worsening the underlying pain condition over time. The Gut as an Inflammation Factory — How Dysbiosis Fuels Body Pain The gut is the largest immune organ in the body — hosting 70–80% of immune cells and functioning as the primary interface between the internal and external environment. When the gut microbiome is disrupted (dysbiosis) and the intestinal lining is compromised (leaky gut), the gut becomes a source of sustained systemic inflammation. Gut-derived inflammation and body pain propagation: • LPS (lipopolysaccharide) from gram-negative bacteria crosses the compromised gut barrier and activates TLR4 (Toll-like receptor 4) on immune cells, triggering NF-kB and a broad pro-inflammatory cytokine response • Dysbiosis reduces short-chain fatty acid (SCFA) production — SCFAs (particularly butyrate) are critical anti-inflammatory signals that regulate NF-kB, maintain the gut lining, and reduce IL-6 and TNF-alpha • Impaired microbiome diversity reduces bile acid metabolism, altering the gut-liver-immune axis • Gut-derived inflammatory signals travel to the brain via the vagus nerve and bloodstream, activating microglia and producing neuroinflammation People with gut conditions (IBS, IBD) have measurably higher rates of widespread body pain, fibromyalgia, and chronic fatigue — directly reflecting the systemic inflammatory consequences of gut dysbiosis.

Steps

1. Neuroinflammation — When Inflammation Reaches the Brain
2. When systemic inflammation is sustained, inflammatory cytokines cross the blood-brain barrier and activate microglia — the brain's resident immune cells. Microglial activation produces neuroinflammation, characterised by elevated CNS levels of IL-6, TNF-alpha, and IL-1beta.
3. Neuroinflammation in chronic pain:
4. • Impairs descending inhibitory pain control (the brain's system for dampening incoming pain signals)
5. • Promotes central sensitisation (the brain amplifies all pain signals regardless of peripheral tissue status)
6. • Produces the cognitive symptoms of chronic pain — brain fog, poor concentration, mood changes
7. • Contributes to the fatigue disproportionate to activity that characterises fibromyalgia and chronic inflammatory conditions
8. • Disrupts sleep architecture, particularly slow-wave sleep — worsening both pain and inflammatory cytokine clearance
9. Neuroinflammation is now understood as a component of multiple chronic pain conditions — including fibromyalgia, chronic lower back pain, migraine, and post-COVID pain — and is a target of both pharmaceutical and nutritional anti-inflammatory approaches.

Related Resources

• Nutritional and Dietary Factors That Drive or Reduce Chronic Inflammation
• Pro-inflammatory dietary pattern: Refined carbohydrates and sugar (activate NF-kB via AGEs and insulin signalling) | Trans fats and excess omega-6 oils (drive arachidonic acid and PGE2 production) | Red and processed meat (saturated fat activating TLR4) | Alcohol (gut permeability and liver NF-kB activation) | Ultra-processed food (multiple inflammatory pathways).
• Anti-inflammatory dietary pattern: Omega-3 fatty acids (EPA/DHA compete with arachidonic acid, producing less inflammatory prostaglandins; directly inhibit NF-kB) | Polyphenols (quercetin, curcumin, resveratrol — NF-kB inhibitors) | Dietary fibre (feeds butyrate-producing bacteria, reduces gut-derived LPS) | Magnesium (reduces IL-6 and CRP; deficiency elevates inflammatory markers) | Vitamin D (transcriptional regulator of immune function, reduces IL-6 and TNF-alpha) | Zinc (modulates NF-kB and reduces oxidative stress).
• The Mediterranean dietary pattern — high in olive oil, fish, vegetables, legumes, and fermented foods — is the most extensively studied anti-inflammatory dietary approach, with documented reductions in CRP, IL-6, and chronic disease risk across multiple long-term studies.

Frequently Asked Questions

Inflammation and body pain are not separate problems — they are the same process at different levels of visibility. When pro-inflammatory cytokines circulate, they sensitise pain nerves. When gut dysbiosis continuously feeds these cytokines into the bloodstream, the pain becomes chronic. When neuroinflammation reaches the brain, that pain becomes amplified and widespread. Understanding this chain — from gut to cytokine to nerve to brain — clarifies what resolving chronic inflammatory pain actually requires. It is not about suppressing symptoms at the prostaglandin level with NSAIDs, but about reducing inflammation at its source: cytokine signalling and NF-kB activation. This is achieved through gut restoration, anti-inflammatory nutrition, stress regulation, and sleep optimisation. The source of the problem is internal. The solution must be internal as well.